Our attorneys have filed a mass tort lawsuit on behalf of patients who took the blood thinner Xarelto (rivaroxaban) and suffered serious bleeding events. Pharmaceutical firms, including the makers of Xarelto, have a duty to make sure that their drugs are reasonably safe for use - and failure to complete so might be grounds for compensation. Our lawyers are working tough to have those hurt by the drug the compensation they may be entitled to.













image class="left" url="http://media1.picsearch.com/is?IRZLmylDSpLyBTpHTom0Osr0NSJ_XXWHyw0FRo22lC0&height=224"Although bleeding is actually a frequent complication associated with anticoagulants, it has been alleged that Xarelto is far more harmful than standard blood thinners simply because no antidote exists to reverse its blood-thinning effects. This implies that, in the occasion of an emergency, sufferers might be at danger for irreversible bleeding difficulties, including life-threatening internal and gastrointestinal hemorrhaging.













If you or perhaps a loved one suffered a critical bleeding occasion soon after taking Xarelto, you may have legal recourse. For a lot more details, get in touch with us today to have your case reviewed, cost-free of charge.






Compensation Possibilities













xarelto-compensation-photoThe plaintiffs in these lawsuits are in search of compensation from Bayer and Janssen for previous and future healthcare bills, lost wages, pain and suffering and, in instances of death, funeral expenses. In addition, they are looking for punitive damages, which are usually awarded to punish the defendant and deter other businesses from acting similarly.






Why Are Lawsuits Being Filed?













Bayer and Johnson & Johnson’s Janssen Pharmaceuticals, Inc. are facing several Xarelto lawsuits alleging that the drug is harmful and defective. The plaintiffs claim that, unlike conventional anticoagulants (e.g. warfarin, Coumadin) whose eltanew.demosite.otenet.gr blood-thinning effects can be reversed using vitamin K, there is no antidote available for Xarelto. Simply because of this, the lawsuits claim, doctors have no effective indicates of stopping Xarelto users from bleeding inside the occasion of an emergency. Plaintiffs inside the lawsuits allege significant and fatal injuries, which includes cerebral hemorrhaging and gastrointestinal bleeds, from use of the drug.













In addition to these risks, lawsuits against Bayer and Johnson & Johnson’s Janssen Pharmaceuticals are alleging:













The manufacturers of Xarelto marketed the drug as a superior in the field of anticoagulants despite studies finding higher rates of gastrointestinal (GI tract) bleeding and transfusions in Xarelto users than users of certain competitors.






The makers of the drug continue to market Xarelto as a protected anticoagulant option.






Doctors and healthcare staff were not properly made aware of methods to stabilize and treat a Xarelto user in the occasion of a bleeding complication.






Users of Xarelto were not adequately warned of the health risks of suffering a fatal bleeding event.






Xarelto is linked to serious bleeding complications, excessive blood loss, intracranial hemorrhaging, eye bleeding (vitreous hemorrhage), stomach bleeding, gastrointestinal bleeding, wound infections from inhibited clotting, and lack of effectiveness in preventing hazardous clotting.













Visit this page for far more info on the alleged health risks of Xarelto.






Multidistrict Litigation Trial Dates Set













image class="left" url="https://images60.fotki.com/v778/photos/2/3651632/13703394/Xareltosideeffects250515-vi.jpg"The attorneys inside the Complex Litigation Group have filed lawsuits on behalf of injured clients. The claims will proceed through multidistrict litigation (MDL), which currently entails four trials, scheduled for Fall 2016, in which random groups of plaintiffs will be chosen to represent the group.
There are no comments on this page.
Valid XHTML :: Valid CSS: :: Powered by WikkaWiki